MedPath

Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)

Generic Name
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)
Brand Names
Adacel, Boostrix, Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quadracel, Vaxelis
Drug Type
Biotech
Unique Ingredient Identifier
8C367IY4EY

Overview

Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

EMA Drug Approvals

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
ADACEL®-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
SIN15479P
INJECTION, SUSPENSION
5 µg/ 0.5 ml
5/8/2018
BOOSTRIX VACCINE
SIN11845P
INJECTION
8 mcg/0.5 ml
3/9/2002
INFANRIX IPV+HIB VACCINE
SIN10988P
INJECTION
25mcg/0.5ml
6/25/1999
PERTAGEN® SUSPENSION FOR INJECTION 0.5 ML/DOSE
SIN16283P
INJECTION, SUSPENSION
5 ug/0.5 ml
7/23/2021
HEXAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
SIN14834P
INJECTION, SUSPENSION
25 μg/0.5 mL
8/25/2015
INFANRIX HEXA VACCINE
SIN12288P
INJECTION
25 mcg/0.5 ml
5/7/2003
Tetraxim Vaccine
SIN15026P
INJECTION, SUSPENSION
25 μg/0.5ml
6/6/2016
BOOSTAGEN SUSPENSION FOR INJECTION
SIN16493P
INJECTION, SUSPENSION
5 ug/0.5 ml
5/18/2022
PENTAXIM VACCINE
SIN14795P
INJECTION, POWDER, FOR SUSPENSION
25 μg/0.5 mL
6/5/2015
Adacel®, Suspension for Injection
SIN14232P
INJECTION, SUSPENSION
5 micrograms
9/20/2012

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
BOOSTRIX VACCINE
N/A
N/A
N/A
8/8/2001
BOOSTRIX POLIO VACCINE
N/A
N/A
N/A
5/31/2007
ADACEL POLIO VACCINE
N/A
N/A
N/A
5/15/2008

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
BOOSTRIX
02247600
Suspension - Intramuscular
8 MCG / 0.5 ML
5/29/2007
INFANRIX-IPV
02241284
Suspension - Intramuscular
25 MCG / 0.5 ML
10/25/2012
QUADRACEL
02534789
Suspension - Intramuscular
20 MCG / 0.5 ML
5/6/2024
PEDIACEL
02243167
Suspension - Intramuscular
20 MCG / 0.5 ML
10/4/2007
BOOSTRIX-POLIO
02312557
Suspension - Intramuscular
8 MCG / 0.5 ML
10/22/2010
TRIPACEL HYBRID
02224143
Suspension - Intramuscular
20 MCG / 0.5 ML
1/23/1997
ADACEL
02240255
Suspension - Intramuscular
5 MCG / 0.5 ML
6/23/1999
PENTACEL
02534797
Suspension - Intramuscular
20 MCG / 0.5 ML
5/6/2024
ADACEL-POLIO
02352044
Suspension - Intramuscular
5 MCG / 0.5 ML
3/11/2011
QUADRACEL
02230946
Suspension - Intramuscular
20 MCG / 0.5 ML
6/20/1997

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.